Search research articles
Contact Us
Filters
Showing results (201-210 of 293) with videos related to
Page
of 30
Sort By:
Open Forum Infectious Diseases
|
March 31, 2025
Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis
Alice Wheeler, Jeffrey Masters, Alyssa Pradhan, et al.
Plos One
|
July 21, 2015
The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis
François M J Lamoury, Brendan Jacka, Sofia Bartlett, et al.
The Medical Journal of Australia
|
March 6, 2022
Australian consensus recommendations for the management of hepatitis B
John S Lubel, Simone I Strasser, Alexander J Thompson, et al.
The American Journal of Cardiology
|
December 31, 1997
Predictors of acute and long-term outcome with transluminal extraction atherectomy: the New Approaches to Coronary Intervention (NACI) registry
M H Sketch, C J Davidson, W Yeh, et al.
Journal of Viral Hepatitis
|
April 17, 2018
Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection
M Martinello, S Bhagani, E Gane, et al.
Ebiomedicine
|
March 22, 2024
Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy
Kasha P Singh, Anchalee Avihingsanon, Jennifer M Zerbato, et al.
Hepatology Communications
|
November 3, 2021
High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study
Jasmine Yee, Joanne M Carson, Behzad Hajarizadeh, et al.
JHEP Reports : Innovation in Hepatology
|
September 29, 2023
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study
Marianne Martinello, Sanjay Bhagani, David Shaw, et al.
Journal of Viral Hepatitis
|
May 18, 2022
Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort
Joanne M Carson, Behzad Hajarizadeh, Josh Hanson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 2, 2011
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C
G V Matthews, S T Pham, M Hellard, et al.
Page
of 30
Search research articles
Search
Showing results (201-210 of 293) with videos related to
Sort By:
Page
of 30
Open Forum Infectious Diseases
|
March 31, 2025
Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis
Alice Wheeler, Jeffrey Masters, Alyssa Pradhan, et al.
Plos One
|
July 21, 2015
The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis
François M J Lamoury, Brendan Jacka, Sofia Bartlett, et al.
The Medical Journal of Australia
|
March 6, 2022
Australian consensus recommendations for the management of hepatitis B
John S Lubel, Simone I Strasser, Alexander J Thompson, et al.
The American Journal of Cardiology
|
December 31, 1997
Predictors of acute and long-term outcome with transluminal extraction atherectomy: the New Approaches to Coronary Intervention (NACI) registry
M H Sketch, C J Davidson, W Yeh, et al.
Journal of Viral Hepatitis
|
April 17, 2018
Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection
M Martinello, S Bhagani, E Gane, et al.
Ebiomedicine
|
March 22, 2024
Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy
Kasha P Singh, Anchalee Avihingsanon, Jennifer M Zerbato, et al.
Hepatology Communications
|
November 3, 2021
High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study
Jasmine Yee, Joanne M Carson, Behzad Hajarizadeh, et al.
JHEP Reports : Innovation in Hepatology
|
September 29, 2023
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study
Marianne Martinello, Sanjay Bhagani, David Shaw, et al.
Journal of Viral Hepatitis
|
May 18, 2022
Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort
Joanne M Carson, Behzad Hajarizadeh, Josh Hanson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 2, 2011
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C
G V Matthews, S T Pham, M Hellard, et al.
Page
of 30